Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC

Audrey Zarba, Christopher P. Wild, Andrew J. Hall, Ruggero Montesano, Geoffrey J. Hudson, John Davis Groopman

Research output: Contribution to journalArticle

Abstract

Maternal to child exposure of aflatoxin M1 in breast milk is an underevaluated risk factor from dietary exposure to aflatoxin B1. A molecular dosimetry study in The Gambia, West Africa, was initiated to explore the relationships between dietary intake of aflatoxins during a 1 week period and a number of aflatoxin biomarkers including aflatoxin metabolite excretion into breast milk. For the breast milk study, five lactating women were identified and milk samples were collected by hand expression once a day during days 3-7 for three women and during days 3-6 for the two other women. Aflatoxin M1 (AFM1) in human milk was measured in all five subjects by a preparative monoclonal antibody immunoaffinity column/HPLC method. In three of the five women, aflatoxin G1 was found. Estimates of the percentage of aflatoxin in the diet excreted as AFM1 in milk ranged from 0.09 to 0.43%. Thus, these data indicate that a rapid methodology exists to assess the levels of AFM1 excretion in human milk and to use this approach as a biomarker for exposure of children to this carcinogen.

Original languageEnglish (US)
Pages (from-to)891-894
Number of pages4
JournalCarcinogenesis
Volume13
Issue number5
StatePublished - May 1992

Fingerprint

Aflatoxin M1
Aflatoxins
Gambia
Western Africa
Monoclonal antibodies
Monoclonal Antibody
High-performance Liquid Chromatography
Human Milk
Chromatography
High Pressure Liquid Chromatography
Monoclonal Antibodies
Biomarkers
Risk Factors
Milk
Percentage
Aflatoxin B1
Methodology
Carcinogens
Estimate
Hand

ASJC Scopus subject areas

  • Cancer Research
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Physiology (medical)
  • Physiology
  • Behavioral Neuroscience

Cite this

Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. / Zarba, Audrey; Wild, Christopher P.; Hall, Andrew J.; Montesano, Ruggero; Hudson, Geoffrey J.; Groopman, John Davis.

In: Carcinogenesis, Vol. 13, No. 5, 05.1992, p. 891-894.

Research output: Contribution to journalArticle

Zarba, Audrey ; Wild, Christopher P. ; Hall, Andrew J. ; Montesano, Ruggero ; Hudson, Geoffrey J. ; Groopman, John Davis. / Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC. In: Carcinogenesis. 1992 ; Vol. 13, No. 5. pp. 891-894.
@article{ac596f05f91c41ceba09af451724f356,
title = "Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC",
abstract = "Maternal to child exposure of aflatoxin M1 in breast milk is an underevaluated risk factor from dietary exposure to aflatoxin B1. A molecular dosimetry study in The Gambia, West Africa, was initiated to explore the relationships between dietary intake of aflatoxins during a 1 week period and a number of aflatoxin biomarkers including aflatoxin metabolite excretion into breast milk. For the breast milk study, five lactating women were identified and milk samples were collected by hand expression once a day during days 3-7 for three women and during days 3-6 for the two other women. Aflatoxin M1 (AFM1) in human milk was measured in all five subjects by a preparative monoclonal antibody immunoaffinity column/HPLC method. In three of the five women, aflatoxin G1 was found. Estimates of the percentage of aflatoxin in the diet excreted as AFM1 in milk ranged from 0.09 to 0.43{\%}. Thus, these data indicate that a rapid methodology exists to assess the levels of AFM1 excretion in human milk and to use this approach as a biomarker for exposure of children to this carcinogen.",
author = "Audrey Zarba and Wild, {Christopher P.} and Hall, {Andrew J.} and Ruggero Montesano and Hudson, {Geoffrey J.} and Groopman, {John Davis}",
year = "1992",
month = "5",
language = "English (US)",
volume = "13",
pages = "891--894",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Aflatoxin M1 in human breast milk from the Gambia, West Africa, quantified by combined monoclonal antibody immunoaffinity chromatography and HPLC

AU - Zarba, Audrey

AU - Wild, Christopher P.

AU - Hall, Andrew J.

AU - Montesano, Ruggero

AU - Hudson, Geoffrey J.

AU - Groopman, John Davis

PY - 1992/5

Y1 - 1992/5

N2 - Maternal to child exposure of aflatoxin M1 in breast milk is an underevaluated risk factor from dietary exposure to aflatoxin B1. A molecular dosimetry study in The Gambia, West Africa, was initiated to explore the relationships between dietary intake of aflatoxins during a 1 week period and a number of aflatoxin biomarkers including aflatoxin metabolite excretion into breast milk. For the breast milk study, five lactating women were identified and milk samples were collected by hand expression once a day during days 3-7 for three women and during days 3-6 for the two other women. Aflatoxin M1 (AFM1) in human milk was measured in all five subjects by a preparative monoclonal antibody immunoaffinity column/HPLC method. In three of the five women, aflatoxin G1 was found. Estimates of the percentage of aflatoxin in the diet excreted as AFM1 in milk ranged from 0.09 to 0.43%. Thus, these data indicate that a rapid methodology exists to assess the levels of AFM1 excretion in human milk and to use this approach as a biomarker for exposure of children to this carcinogen.

AB - Maternal to child exposure of aflatoxin M1 in breast milk is an underevaluated risk factor from dietary exposure to aflatoxin B1. A molecular dosimetry study in The Gambia, West Africa, was initiated to explore the relationships between dietary intake of aflatoxins during a 1 week period and a number of aflatoxin biomarkers including aflatoxin metabolite excretion into breast milk. For the breast milk study, five lactating women were identified and milk samples were collected by hand expression once a day during days 3-7 for three women and during days 3-6 for the two other women. Aflatoxin M1 (AFM1) in human milk was measured in all five subjects by a preparative monoclonal antibody immunoaffinity column/HPLC method. In three of the five women, aflatoxin G1 was found. Estimates of the percentage of aflatoxin in the diet excreted as AFM1 in milk ranged from 0.09 to 0.43%. Thus, these data indicate that a rapid methodology exists to assess the levels of AFM1 excretion in human milk and to use this approach as a biomarker for exposure of children to this carcinogen.

UR - http://www.scopus.com/inward/record.url?scp=0026611181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026611181&partnerID=8YFLogxK

M3 - Article

C2 - 1587004

AN - SCOPUS:0026611181

VL - 13

SP - 891

EP - 894

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 5

ER -